A shadow market for unapproved slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Treatment Gaining Popularity Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.
Active Commerce on Social Networks
Separately, a robust market exists on messaging services, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Experts Voice Worries
Nevertheless, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of uncertain source.
Some professionals said the popularity for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on social media or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.
Platform Response and Content Removal
According to the social media company, the platform has removed violative material and banned related keywords and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in enhancing compliance measures.
Online Marketplace Activities
Research also discovered groups with up to nine thousand members selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of users, populated with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.
After moments of entering one community, a seller posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised delivery within two days. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about weight, medical conditions or past usage.
Item Information and Costs
Inside these groups, messages show black plastic packages with postal service stickers, claiming to contain new batches. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20mg. When questioned how much time a injector should be used, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service stated it actively moderated harmful content on its platform including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they can’t verify. Even if the science behind retatrutide is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already seen patients injured by self-injection from unconfirmed suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a Lilly experimental product not yet authorized … may subject users to possibly serious health risks”.
